Warburton, L.
Meniawy, T. M.
Calapre, L.
Pereira, M.
McEvoy, A.
Ziman, M.
Gray, E. S. http://orcid.org/0000-0002-8613-3570
Millward, M.
Funding for this research was provided by:
National Health and Medical Research Council (1190643, 1117911)
WA Cancer and Palliative Care Network
Western Australian Health Translation Network
Department of Health, Government of Western Australia
Cancer Council of Western Australia
Article History
Received: 8 August 2020
Accepted: 21 October 2020
First Online: 2 November 2020
Competing interests
: The following authors have received travel support from: T.M.M. [Bristol-Myers Squibb (BMS), Novartis, AstraZeneca (AZ)] and E.S.G. [Merck Sharp and Dohme (MSD) and Bio-Rad]. The following authors sit on advisory boards for: T.M.M. [BMS, MSD, Novartis, AZ] and M.M. [BMS, AZ, Roche, MSD]. The other authors declare no competing interests.